In a letter addressed to Xavier Becerra, Secretary of Health and Human Services, and Dr. Mandy Cohen, Director of the US CDC, Africa CDC Director General Dr. Jean Kaseya highlighted Rwanda's substantial progress in controlling and managing the outbreak.
As of November 17, it has been 18 days since Rwanda reported its last Marburg Virus Disease (MVD) case. All previously infected patients have been successfully discharged, while rigorous monitoring and community follow-up systems remain in place. Additionally, 100% of identified contacts completed the required monitoring period.
Rwanda's achievement is attributed to the swift and coordinated efforts led by its Ministry of Health, in collaboration with Africa CDC, the World Health Organization (WHO), and international partners.
Key measures included enhanced nationwide surveillance for early case detection, innovative approaches to contact tracing and isolation, upgraded treatment facilities meeting global standards, and widespread public awareness campaigns on prevention.
The Marburg virus outbreak was first declared in Rwanda on September 27, 2024. Since then, the country has worked diligently to contain the virus and prevent its spread within Rwanda and across the continent.
During Africa CDC's weekly media briefing, Rwanda's Minister of Health, Dr. Sabin Nsanzimana, stated: 'More than a month without a death from Marburg is indicative of the sound progress we have made, but the country remains vigilant.'
Surveillance efforts have been extended to include monitoring fruit bats, the source of the index case, and all caves in the country.
Based on current data, the MVD index case originated from a single zoonotic transmission. Of the 66 reported cases, Rwanda has recorded 51 recoveries. Efforts continue to follow up on survivors and monitor those who have recovered.
Dr. Nsanzimana further noted, 'The case fatality rate for those who did not make it has been maintained at 22.7%, which is relatively lower compared to previous outbreaks in the region. The deployment of new tools, therapeutics, and vaccines has contributed significantly to these outcomes.'
Recent evaluations by Africa CDC and WHO acknowledge Rwanda's progress, confirming a low risk of further MVD transmission. No cases have been reported outside Rwanda or in the United States.
Africa CDC has urged the U.S. HHS and CDC to collaborate with international health agencies to reassess the situation and update the travel advisory to reflect Rwanda's current epidemiological status.
Dr. Kaseya emphasized that revising the advisory 'would recognize Rwanda's public health achievements while supporting its economic recovery.'
He also reaffirmed the strong partnership between Africa CDC and the United States in advancing global health security.
In a statement released on November 18, 2024, Africa CDC reiterated its commitment to protecting public health across Africa and collaborating with global partners to enhance health security.
Africa CDC, an autonomous public health agency of the African Union, supports member states in strengthening health systems, improving disease surveillance, and enhancing emergency response and disease control efforts.
Théophile Niyitegeka
